Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CVNA vs GSK✓SelectedUSD · GSKCVNA vs GSK performance historyLatest closeAs of-6.10%11/20
Stock and ETF performance explorer

CVNA vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+12.1%
GSK return
+40.7%
Excess return
-28.5%
Maximum drawdown
-98.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-6.1%-0.1%-6.0%-6.1%
7D-11.8%-5.3%-6.4%-10.5%
30D+7.9%-3.7%+11.5%+8.9%
3M-10.7%-7.3%-3.5%-9.1%
6M-1.6%-4.2%+2.6%-0.9%
YTD-24.4%+0.9%-25.2%-25.0%
1Y+1.9%+7.3%-5.4%-0.6%
3Y+863.9%+52.7%+811.2%+679.3%
All+12.1%+40.7%-28.5%-6.3%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling